The global Leukemia Therapeutics Market Size was valued at USD 17.2 billion in 2023 and is projected to reach USD 32.3 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2024 to 2032, according to a new industry report. This growth is fueled by increasing leukemia prevalence, significant advancements in precision medicine, and strong...